These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21397755)

  • 21. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
    Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sinus arrest as a result of rivastigmine in an elderly dementia with Lewy bodies patient.
    Muto S; Kawano H; Nakatomi D; Yamasa T; Maemura K
    Geriatr Gerontol Int; 2015 Feb; 15(2):229-30. PubMed ID: 25619267
    [No Abstract]   [Full Text] [Related]  

  • 23. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
    Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G
    Am J Alzheimers Dis Other Demen; 2004; 19(6):333-9. PubMed ID: 15633941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke].
    Litvineneko IV; Odinak MM; Khlystov IuV; Perstnev SV; Fedorov BB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):36-41. PubMed ID: 21389938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rivastigmine patches: line extension. No therapeutic advantage and less convenient than capsules.
    Prescrire Int; 2009 Feb; 18(99):19. PubMed ID: 19391277
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinesterase inhibitors and delirium after cardiac surgery.
    Yazigi A; Madi-Jebara S; Haddad F; Hayek G
    Crit Care Med; 2010 Apr; 38(4):1231. PubMed ID: 20335721
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
    Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
    Wattmo C; Wallin AK; Londos E; Minthon L
    Gerontologist; 2011 Feb; 51(1):17-27. PubMed ID: 20562471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.
    Leikin JB; Braund V; DesLauris C
    Am J Emerg Med; 2014 Jul; 32(7):815.e3-4. PubMed ID: 24589024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCI treatment trials: failure or not?
    Petersen RC
    Lancet Neurol; 2007 Jun; 6(6):473-5. PubMed ID: 17509475
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.
    Massoudi N; Mohit B; Fathi M; Nooraei N; Hannani KK; ArianNik M
    Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5970. PubMed ID: 37485727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you!
    Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability.
    Kinnair D; Machili C; Prettyman R; Van Diepen E
    Int J Geriatr Psychiatry; 2011 Mar; 26(3):328-9. PubMed ID: 21319335
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adding rivastigmine to antipsychotics in the treatment of a chronic delirium.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Age Ageing; 2004 Sep; 33(5):516-7. PubMed ID: 15315924
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-based delirium treatment approaches].
    Hammann F; Drewe J
    Ther Umsch; 2010 Feb; 67(2):91-4. PubMed ID: 20131219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domperidone is effective in the prevention of rivastigmine-related gastrointestinal disturbances.
    Scarzella L; Costanza A; Vastola K
    Funct Neurol; 2007; 22(2):101-4. PubMed ID: 17637213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reexamining cholinesterase inhibitors for the prevention and treatment of delirium in high-risk populations.
    Lieberman OJ; Douglas VC; LaHue SC
    Crit Care; 2023 Mar; 27(1):129. PubMed ID: 37004115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.